Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
30 participants
INTERVENTIONAL
2018-11-12
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The randomization method is block balanced randomization. All patients will ask to fulfill the ethical Form. This form acquired demographic information (e.g. age, sex) about patients. A panoramic radiograph will take from those who matched the inclusion criteria and signed the agreement. Then a tooth from one side will be treated and the tooth from the other side of the mouth will treat at least 2 weeks later by the same dentist.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IANB without panoramic
They will get Ianb without using panoramic
IANB by the guide of Panoramic
IANB will be injected by the guide of panoramic radiograph
IANB without the guide of Panoramic
IANB will be injected without the guide of panoramic radiograph, in the routine way.
IANB with panoramic
They will get IANB by the guide of panoramic
IANB by the guide of Panoramic
IANB will be injected by the guide of panoramic radiograph
IANB without the guide of Panoramic
IANB will be injected without the guide of panoramic radiograph, in the routine way.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IANB by the guide of Panoramic
IANB will be injected by the guide of panoramic radiograph
IANB without the guide of Panoramic
IANB will be injected without the guide of panoramic radiograph, in the routine way.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physically and mentally healthy patients who could express their pain.
* having panoramic radiograph from the past six months for other dental purposes.
Exclusion Criteria
* patients with acute or chronic pericoronitis.
* pregnancy
* trismus
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hormozgan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sajad Ansari Fard
PhD, Student research committee
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hossein Dabbagh, Md, PhD
Role: STUDY_CHAIR
Persian Gulf Oral and Dental Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dental clinic of BandarAbbas faculty of dentistry
BandarAbbas, Hormozgan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hossein Dabbagh, Md, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMS 50126
Identifier Type: -
Identifier Source: org_study_id